New Zealand markets closed

Galectin Therapeutics Inc. (GALT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.72000.0000 (0.00%)
At close: 04:00PM EDT
2.7200 0.00 (0.00%)
After hours: 07:34PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-41,028
-41,066
-38,776
-30,527
-23,465
-
Depreciation & amortisation
10
33
32
41
36
-
Stock-based compensation
2,203
2,261
2,867
2,076
1,799
-
Change in working capital
3,246
4,678
4,968
3,957
942
-
Accounts payable
750
2,671
4,244
3,686
2,536
-
Other working capital
-34,277
-32,965
-31,056
-24,308
-20,601
-
Other non-cash items
761
697
410
283
87
-
Net cash provided by operating activities
-34,277
-32,965
-31,056
-24,308
-20,601
-
Cash flows from investing activities
Net cash used for investing activities
-
0
0
0
0
-
Cash flows from financing activities
Common stock issued
-
-
0
6,814
263
50,469
Dividends paid
-
-
-
-
0
-394
Net cash used provided by (used for) financing activities
40,033
40,033
10,000
36,814
263
-
Net change in cash
5,756
7,068
-21,056
12,506
-20,338
-
Cash at beginning of period
17,999
18,592
39,648
27,142
47,480
-
Cash at end of period
23,555
25,660
18,592
39,648
27,142
-
Free cash flow
Operating cash flow
-34,277
-32,965
-31,056
-24,308
-20,601
-
Free cash flow
-34,277
-32,965
-31,056
-24,308
-20,601
-